英国的学术药物发现单位:进展和挑战
Michael M Hopkins1, Jorge Mestre-Ferrandiz1, Phillipa Crane1
1Science Policy Research Unit, University of Sussex Business School, University of Sussex, Falmer, Brighton BN1 9SL, UK.
Drug discovery today
|January 4, 2025
概括
英国学术药物发现单位 (DDU) 协调翻译性研究,将学术界和工业界联系起来. 虽然存在合作,但将药物推向市场和确保可持续资金仍然是这些重要研究中心面临的关键挑战.
科学领域:
- 制药科学 制药科学
- 翻译医学是一种翻译医学.
- 生物技术是生物技术.
背景情况:
- 学术药物发现的贡献在美国得到了充分的记录,但在全球范围内人们对其理解较少.
- 药物发现单位 (DDU) 正在成为早期药物开发的关键促进者.
- 翻译性研究将学术见解与药物商业化工业能力相结合.
研究的目的:
- 检查英国药物发现单位 (DDU) 在学术药物发现领域的作用和影响.
- 确定DDU在将学术研究转化为可销售的治疗方法方面所取得的进展和面临的挑战.
- 为协调早期药物管道活动提供英国特有的视角.
主要方法:
- 对英国药物发现单位的公开数据的分析.
- 采访来自英国多个DDU的员工,以收集见解.
- 在协调翻译研究和行业合作方面评估DDU活动.
主要成果:
- DDU已经成功与制药行业的合作伙伴建立了合作关系.
- 大多数DDU仍处于推进候选药物进入市场批准的早期阶段.
- 可持续的融资模式对DDU运营产生了重大和日益严重的关注.
结论:
- 英国DDU在翻译性研究中发挥着至关重要的作用,将学术创新与工业联系起来.
- 尽管在合作方面取得了进展,但从学术发现到市场的旅程仍然漫长而复杂.
- 确保长期的财务可行性对于DDU在药物开发中的持续成功和影响至关重要.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Control Governance: Regulatory Bodies and Their Impact
139
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
139
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Administration and Therapy Phases: Overview
406
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
406


